Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy
| dc.contributor.author | Silva, Ana Paula | |
| dc.contributor.author | Perdigão, Margarida | |
| dc.contributor.author | Espírito Santo, Margarida | |
| dc.contributor.author | Advinha, Ana Margarida | |
| dc.date.accessioned | 2026-02-13T15:28:02Z | |
| dc.date.available | 2026-02-13T15:28:02Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy | por |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.citation | Silva AP, Perdigão M, Espírito Santo M, Advinha AM. Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy. In: Abstracts of the 4th Annual Summit of the Comprehensive Health Research Centre (CHRC). Évora, Portugal: Port J Public Health, 42(suppl1); 2024. pp.13. | por |
| dc.identifier.doi | https://doi.org/10.1159/000539013 | por |
| dc.identifier.uri | https://karger.com/pjp/article/42/Suppl.%201/1/907543/Book-of-Abstracts-of-the-4th-CHRC-Annual-Summit | |
| dc.identifier.uri | http://hdl.handle.net/10174/41161 | |
| dc.language.iso | por | por |
| dc.peerreviewed | no | por |
| dc.rights | openAccess | por |
| dc.title | Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy | por |
| dc.type | article |